Almost 50 new psychoactive substances were reported to EU in 2011BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7865 (Published 20 November 2012) Cite this as: BMJ 2012;345:e7865
- Rory Watson
The European drugs scene is becoming increasingly complex as users are confronted with a wide variety of powders and pills, says the latest annual report from the Lisbon based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).1
Cocaine, ecstasy, and amphetamines are the most widely used stimulants but are now competing with a growing number of new synthetic drugs such as cathinones. In 2011 a record 49 new psychoactive substances were officially notified to the European Union’s early warning system—averaging almost one every week.
The number is an increase on the 41 reported in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial